← TrialMatch
HomeTrials

High Resolution Anuscopy Study

The majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillo

Condition(s)Human Papilloma Virus, Anal Squamous Cell Carcinoma
StatusRecruiting
Study typeObservational
SummaryThe majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillomavirus (HR HPV). HRA referral is recommended for individuals with abnormal cytology. HRA represents the only method to identify precancerous lesions of the anal canal, with only few specialists knowledgeable about it. At UZ Brussel, the investigators collected a wealth of data about HPV infection and its association with anal pathology. By establishing a comprehensive study, the investigators can delve into this data with specific research questions, conducting valuable rese
Who can participateInclusion Criteria: * All patients who have undergone HRA and all future patients referred for HRA in UZ Brussel * 18 years or older * Understands and able to speak and write in French, Dutch or English Exclusion Criteria: * None
Ages18 Years
SexAll
Lead sponsorUniversitair Ziekenhuis Brussel
LocationsJette, Belgium
Start date2024-08-08
NCT IDNCT06697964
Official listinghttps://clinicaltrials.gov/study/NCT06697964

🔍 Search all trials →